Crohn’s patients with higher Remicade levels may not benefit from azathioprine

Print Friendly, PDF & Email
Patients with Crohn’s disease who have high serum concentrations of Remicade may not see additional clinical benefits from combination therapy with azathioprine, according to a post hoc analysis of the SONIC trial presented during a session focused on therapeutic drug monitoring in IBD at Digestive Disease Week.  

Read Full Article from Source →

© Copyright 2013 Endoscopy Center. All Rights Reserved Privacy Policy | Site Map

Back to the Top